Literature DB >> 10393600

Inhalation therapy in asthma: nebulizer or pressurized metered-dose inhaler with holding chamber? In vivo comparison of lung deposition in children.

J H Wildhaber1, N D Dore, J M Wilson, S G Devadason, P N LeSouëf.   

Abstract

OBJECTIVE: To compare lung deposition from a nebulizer and a pressurized metered-dose inhaler (pMDI)/holding chamber to determine their efficiency in aerosol delivery to children. STUDY
DESIGN: Children with stable asthma (n = 17) aged 2 to 9 years inhaled in random order radiolabeled salbutamol from a nebulizer and a pMDI through a nonstatic holding chamber. Body and lung deposition of radiolabeled salbutamol was assessed with a gamma camera.
RESULTS: Mean (absolute dose) total lung deposition expressed as a percentage of the nebulized dose was 5.4% (108 microg) in younger children (<4 years) and 11.1% (222 microg) in older children (>4 years). Mean (absolute dose) total lung deposition expressed as a percentage of the metered dose was 5.4% (21.6 microg) in younger and 9.6% (38.4 microg) in older children.
CONCLUSIONS: For the same age groups we have shown equivalent percentages of total lung deposition of radiolabeled salbutamol aerosolized by either a nebulizer or a pMDI/holding chamber. However, the delivery rate per minute and the total dose of salbutamol deposited were significantly higher for the nebulizer.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10393600     DOI: 10.1016/s0022-3476(99)70323-9

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  26 in total

1.  Micron-sized intrapulmonary particle deposition in the developing rat lung.

Authors:  Holger Schulz; Gunter Eder; Ines Bolle; Akira Tsuda; Stefan Karrasch
Journal:  J Appl Physiol (1985)       Date:  2011-12-08

Review 2.  Management of acute pediatric asthma.

Authors:  John C Carl; Carolyn M Kercsmar
Journal:  Curr Allergy Asthma Rep       Date:  2002-11       Impact factor: 4.806

Review 3.  Maybe there is no such thing as bronchiolitis.

Authors:  Brian A Kuzik
Journal:  CMAJ       Date:  2016-02-01       Impact factor: 8.262

4.  Inhalation devices.

Authors: 
Journal:  CMAJ       Date:  2005-09-13       Impact factor: 8.262

5.  Age dependent systemic exposure to inhaled salbutamol.

Authors:  Klaus Bønnelykke; Jakob Jessing Jespersen; Hans Bisgaard
Journal:  Br J Clin Pharmacol       Date:  2007-03-01       Impact factor: 4.335

Review 6.  A path to successful patient outcomes through aerosol drug delivery to children: a narrative review.

Authors:  Arzu Ari
Journal:  Ann Transl Med       Date:  2021-04

7.  Achieving control of asthma in preschoolers.

Authors:  Thomas Kovesi; Suzanne Schuh; Sheldon Spier; Denis Bérubé; Stuart Carr; Wade Watson; R Andrew McIvor
Journal:  CMAJ       Date:  2009-11-23       Impact factor: 8.262

Review 8.  Antiasthmatic drug delivery in children.

Authors:  Elizabeth Biggart; Andrew Bush
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

9.  Tolerability and pharmacokinetics of inhaled bimosiamose disodium in healthy males.

Authors:  Michael Meyer; Kai-Michael Beeh; Jutta Beier; Diana Beyer; Ewald Aydt; Rainer Zahlten; Bernd Jilma; Gerhard Wolff
Journal:  Br J Clin Pharmacol       Date:  2006-09-20       Impact factor: 4.335

10.  Asthma Review for Pharmacists Providing Asthma Education.

Authors:  Stacie J Lampkin; Cheryl A Maslouski; William A Maish; Barnabas M John
Journal:  J Pediatr Pharmacol Ther       Date:  2016 Sep-Oct
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.